Recently Viewed
Clear All$0.03
$0.00
(4.35%)
As on 25-Oct-2023 09:30EDT
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$2 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$-23 Mln
ROE
-8.7 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
6.1
Industry P/E
--
EV/EBITDA
-0.2
Div. Yield
0 %
Debt to Equity
--
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
9,815,560
CFO
$-64.66 Mln
EBITDA
$-107.48 Mln
Net Profit
$-101.26 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
G Medical Innovations Holdings (GMVD)
| -99.0 | -44.5 | -90.7 | -99.5 | -91.4 | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
Company
|
2022
|
|---|---|
|
G Medical Innovations Holdings (GMVD)
| -94.4 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The... company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel. Read more
Pres, CEO, MD & Exec. Director
Dr. Yacov Geva
Pres, CEO, MD & Exec. Director
Dr. Yacov Geva
Headquarters
Rehovot
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of G Medical Innovations Holdings Ltd (GMVD) is $0.03 (NASDAQ) as of 25-Oct-2023 09:30 EDT. G Medical Innovations Holdings Ltd (GMVD) has given a return of -91.38% in the last 3 years.
Since, TTM earnings of G Medical Innovations Holdings Ltd (GMVD) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
The 52-week high and low of G Medical Innovations Holdings Ltd (GMVD) are Rs -- and Rs -- as of 05-Apr-2026.
G Medical Innovations Holdings Ltd (GMVD) has a market capitalisation of $ 2 Mln as on 25-Oct-2023. As per SEBI classification, it is a company.
Before investing in G Medical Innovations Holdings Ltd (GMVD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.